Results 231 to 240 of about 251,382 (296)

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang   +12 more
wiley   +1 more source

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

A Novel Approach to Care Redesign Collaboration Between Emergency and Specialty Departments: Qualitative Experience Report. [PDF]

open access: yesJMIR Form Res
Harris SR   +13 more
europepmc   +1 more source

Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands. [PDF]

open access: yesRegen Med
Gort J   +6 more
europepmc   +1 more source

Editorial: The digitalization of neurology-volume II. [PDF]

open access: yesFront Digit Health
Hier DB   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy